Bringing emergency contraception over the counter: Experiences of nonprescription users in France, Norway, Sweden and Portugal

Contraception

Volumn 68, Issue 2, 2003, Pages 117-124

  Gainer, Erin ^a   Blum, Jennifer ^b   Toverud, Else Lydia ^c   Portugal, Nuno ^d   Tyden, Tanja ^e   Nesheim, Britt Ingjerd ^f   Larsson, Margareta ^e   Vilar, Duarte ^d   Nymoen, Pernille ^c   Aneblom, Gunilla ^e   Lutwick, Arielle ^g   Winikoff, Beverly ^h  

^a Laboratoire HRA Pharma   (France)

^b POPULATION COUNCIL   (United States)

^c UNIVERSITY OF OSLO   (Norway)

^d Associacao o Planeam da Familia   (Portugal)

^e UPPSALA UNIVERSITY   (Sweden)

^f ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^g Repro Health Technologies Project   (United States)

^h GYNUITY HEALTH PROJECTS   (United States)

Author keywords

Access; Emergency contraception; Over the counter; Pharmacy access

Indexed keywords

NON PRESCRIPTION DRUG; ORAL CONTRACEPTIVE AGENT; POSTCOITUS CONTRACEPTIVE AGENT;

ACCESS TO INFORMATION; ADULT; AGED; ARTICLE; ATTITUDE; CONTRACEPTION; COUNSELING; FEMALE; FRANCE; HUMAN; NORWAY; PHARMACY; PORTUGAL; PRESCRIPTION; QUESTIONNAIRE; SAFETY; STANDARD; SWEDEN; UTILIZATION REVIEW;

EID: 10744232151     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(03)00114-8     Document Type: Article

References (4)

1. Piaggio G., von Hertzen H., Grimes D.A., Van Look P.F. Timing of emergency contraception with levonorgestrel or the Yuzpe regimen. Task Force on Postovulatory Methods of Fertility Regulation. Lancet. 353:(9154):1999;721.
2. Sucato G., Gold M.A. New options in contraception for adolescents. Curr Womens Health Rep. 1:2001;116-123.
3. The International Consortium for Emergency Contraception, February 2003. http://www.cecinfo.org.
4. Rheinstein P.H. Criteria used by the FDA to determine what classes of drugs are suitable switch candidates. Drug Inf J. 19:1985;139-142.